Sepsis in cirrhosis: emerging concepts in pathogenesis, diagnosis and management
- 15 July 2016
- journal article
- review article
- Published by Springer Nature in Hepatology International
- Vol. 10 (6) , 871-882
Abstract
Infections and sepsis are more common in cirrhotic than in the general population and constitute the commonest cause of sudden worsening and death. The diagnosis of systemic inflammatory syndrome and sepsis are challenging in cirrhotics due to an underlying a state of hyperdynamic circulation. Further, poor nutritional and bone marrow reserves lead to modest host immune response, the so called immunoparalysis state and the outcome of antibiotic therapy is suboptimal. In this review, a comprehensive description of current and emerging concepts in the pathogenesis and diagnosis of sepsis with importance to current and novel biomarkers for diagnosis of sepsis in cirrhosis is presented. Furthermore, novel treatment options and preventive strategies are discussed to improve the overall survival.Keywords
This publication has 47 references indexed in Scilit:
- Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsisCritical Care, 2013
- Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosisHepatology, 2012
- Dose-Dependent Effect of Anti-CTLA-4 on Survival in SepsisShock, 2011
- TLR9 and the NLRP3 Inflammasome Link Acinar Cell Death With Inflammation in Acute PancreatitisGastroenterology, 2011
- Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patientsCritical Care, 2011
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Circulating mitochondrial DAMPs cause inflammatory responses to injuryNature, 2010
- Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoidsJournal of Experimental Medicine, 2008
- Neutrophil secretion products regulate anti-bacterial activity in monocytes and macrophagesClinical and Experimental Immunology, 2007
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992